Search Orphan Drug Designations and Approvals
-
| Generic Name: | (6-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)pyrimidin-2-yl)-1-methyl-1H-indol-2-yl)(3,3-difluoroazetidin-1-yl)methanone |
|---|---|
| Date Designated: | 05/08/2019 |
| Orphan Designation: | Treatment of Idiopathic Pulmonary Fibrosis |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Beijing Tide Pharmaceutical Co., Ltd No.8 East Rongjing Street Beijing Econnomic-technological Development Area (BDA) Beijing China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







